ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,495,992, issued on Dec. 16, was assigned to Senseonics Inc. (Germantown, Md.).
"Mediation of in vivo analyte signal degradation" was invented by Joon Chatterjee (Germantown, Md.), Sanat Mohanty (Germantown, Md.), Philip Huffstetler (Germantown, Md.), Venkata Velvadapu (Germantown, Md.) and Leopoldo Torres Jr. (Germantown, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor hou...